Sight Sciences Past Earnings Performance
Past criteria checks 0/6
Sight Sciences's earnings have been declining at an average annual rate of -15.5%, while the Medical Equipment industry saw earnings growing at 8.7% annually. Revenues have been growing at an average rate of 29.1% per year.
Key information
-15.5%
Earnings growth rate
32.1%
EPS growth rate
| Medical Equipment Industry Growth | 8.9% |
| Revenue growth rate | 29.1% |
| Return on equity | -50.1% |
| Net Margin | -67.2% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Recent updates
Sight Sciences, Inc. (NASDAQ:SGHT) Stock Catapults 46% Though Its Price And Business Still Lag The Industry
Dec 19
Some Analysts Just Cut Their Sight Sciences, Inc. (NASDAQ:SGHT) Estimates
Nov 19Sight Sciences Grows Portfolio Amid Reimbursement Pressure
Aug 19Sizing Up Sight Sciences
Jun 26Sight Sciences - Opening My Eyes
Apr 08Analysts Have Been Trimming Their Sight Sciences, Inc. (NASDAQ:SGHT) Price Target After Its Latest Report
Mar 26Sight Sciences: Appeal Is Visually Increasing
Jan 13Revenue & Expenses Breakdown
How Sight Sciences makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 81 | -55 | 107 | 18 |
| 31 Dec 23 | 81 | -56 | 109 | 18 |
| 30 Sep 23 | 83 | -62 | 114 | 19 |
| 30 Jun 23 | 82 | -71 | 119 | 21 |
| 31 Mar 23 | 75 | -80 | 120 | 22 |
| 31 Dec 22 | 71 | -86 | 120 | 23 |
| 30 Sep 22 | 65 | -85 | 114 | 22 |
| 30 Jun 22 | 60 | -80 | 104 | 20 |
| 31 Mar 22 | 55 | -74 | 90 | 18 |
| 31 Dec 21 | 49 | -63 | 76 | 16 |
| 30 Sep 21 | 43 | -56 | 65 | 14 |
| 30 Jun 21 | 39 | -47 | 56 | 12 |
| 31 Mar 21 | 30 | -38 | 46 | 10 |
| 31 Dec 20 | 28 | -35 | 42 | 9 |
| 31 Dec 19 | 23 | -26 | 33 | 8 |
| 31 Dec 18 | 8 | -14 | 14 | 5 |
Quality Earnings: SGHT is currently unprofitable.
Growing Profit Margin: SGHT is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: SGHT is unprofitable, and losses have increased over the past 5 years at a rate of 15.5% per year.
Accelerating Growth: Unable to compare SGHT's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: SGHT is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (2.6%).
Return on Equity
High ROE: SGHT has a negative Return on Equity (-50.13%), as it is currently unprofitable.